JSW Energy Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 17, 2025, 3:43 am

Competitors of JSW Energy Ltd

All Competitor Stocks of JSW Energy Ltd

Quarterly Result

Last Updated: August 1, 2025, 6:45 pm

Below is a detailed analysis of the quarterly data for JSW Energy Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 5,143.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,189.00 Cr. (Mar 2025) to 5,143.00 Cr., marking an increase of 1,954.00 Cr..
• For Expenses, as of Jun 2025, the value is 2,355.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,985.00 Cr. (Mar 2025) to 2,355.00 Cr., marking an increase of 370.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 2,789.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,204.00 Cr. (Mar 2025) to 2,789.00 Cr., marking an increase of 1,585.00 Cr..
• For OPM %, as of Jun 2025, the value is 54.00%. The value appears strong and on an upward trend. It has increased from 38.00% (Mar 2025) to 54.00%, marking an increase of 16.00%.
• For Other Income, as of Jun 2025, the value is 271.00 Cr.. The value appears to be declining and may need further review. It has decreased from 313.00 Cr. (Mar 2025) to 271.00 Cr., marking a decrease of 42.00 Cr..
• For Interest, as of Jun 2025, the value is 1,306.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 675.00 Cr. (Mar 2025) to 1,306.00 Cr., marking an increase of 631.00 Cr..
• For Depreciation, as of Jun 2025, the value is 739.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 482.00 Cr. (Mar 2025) to 739.00 Cr., marking an increase of 257.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 1,015.00 Cr.. The value appears strong and on an upward trend. It has increased from 361.00 Cr. (Mar 2025) to 1,015.00 Cr., marking an increase of 654.00 Cr..
• For Tax %, as of Jun 2025, the value is 18.00%. The value appears to be increasing, which may not be favorable. It has increased from -15.00% (Mar 2025) to 18.00%, marking an increase of 33.00%.
• For Net Profit, as of Jun 2025, the value is 836.00 Cr.. The value appears strong and on an upward trend. It has increased from 415.00 Cr. (Mar 2025) to 836.00 Cr., marking an increase of 421.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 4.25. The value appears strong and on an upward trend. It has increased from 2.33 (Mar 2025) to 4.25, marking an increase of 1.92.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:03 am

Growth

Last Updated: September 5, 2025, 8:30 am

Balance Sheet

Last Updated: July 25, 2025, 2:57 pm

Below is a detailed analysis of the balance sheet data for JSW Energy Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 1,745.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,641.00 Cr. (Mar 2024) to 1,745.00 Cr., marking an increase of 104.00 Cr..
• For Reserves, as of Mar 2025, the value is 25,616.00 Cr.. The value appears strong and on an upward trend. It has increased from 19,191.00 Cr. (Mar 2024) to 25,616.00 Cr., marking an increase of 6,425.00 Cr..
• For Borrowings, as of Mar 2025, the value is 50,185.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 31,573.00 Cr. (Mar 2024) to 50,185.00 Cr., marking an increase of 18,612.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 11,909.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,362.00 Cr. (Mar 2024) to 11,909.00 Cr., marking an increase of 6,547.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 89,455.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 57,767.00 Cr. (Mar 2024) to 89,455.00 Cr., marking an increase of 31,688.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 54,155.00 Cr.. The value appears strong and on an upward trend. It has increased from 28,946.00 Cr. (Mar 2024) to 54,155.00 Cr., marking an increase of 25,209.00 Cr..
• For CWIP, as of Mar 2025, the value is 10,281.00 Cr.. The value appears to be declining and may need further review. It has decreased from 10,285.00 Cr. (Mar 2024) to 10,281.00 Cr., marking a decrease of 4.00 Cr..
• For Investments, as of Mar 2025, the value is 9,755.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,035.00 Cr. (Mar 2024) to 9,755.00 Cr., marking an increase of 2,720.00 Cr..
• For Other Assets, as of Mar 2025, the value is 15,264.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,501.00 Cr. (Mar 2024) to 15,264.00 Cr., marking an increase of 3,763.00 Cr..
• For Total Assets, as of Mar 2025, the value is 89,455.00 Cr.. The value appears strong and on an upward trend. It has increased from 57,767.00 Cr. (Mar 2024) to 89,455.00 Cr., marking an increase of 31,688.00 Cr..

However, the Borrowings (50,185.00 Cr.) are higher than the Reserves (25,616.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for JSW Energy Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 11.19. This value is within the healthy range. It has increased from 10.50 (Mar 24) to 11.19, marking an increase of 0.69.
• For Diluted EPS (Rs.), as of Mar 25, the value is 11.18. This value is within the healthy range. It has increased from 10.47 (Mar 24) to 11.18, marking an increase of 0.71.
• For Cash EPS (Rs.), as of Mar 25, the value is 20.71. This value is within the healthy range. It has increased from 20.36 (Mar 24) to 20.71, marking an increase of 0.35.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 156.78. It has increased from 128.04 (Mar 24) to 156.78, marking an increase of 28.74.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 156.78. It has increased from 128.04 (Mar 24) to 156.78, marking an increase of 28.74.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 67.30. It has decreased from 69.98 (Mar 24) to 67.30, marking a decrease of 2.68.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 35.04. This value is within the healthy range. It has decreased from 35.57 (Mar 24) to 35.04, marking a decrease of 0.53.
• For PBIT / Share (Rs.), as of Mar 25, the value is 25.56. This value is within the healthy range. It has decreased from 25.61 (Mar 24) to 25.56, marking a decrease of 0.05.
• For PBT / Share (Rs.), as of Mar 25, the value is 12.55. This value is within the healthy range. It has decreased from 13.10 (Mar 24) to 12.55, marking a decrease of 0.55.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 11.23. This value is within the healthy range. It has increased from 10.41 (Mar 24) to 11.23, marking an increase of 0.82.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 11.18. This value is within the healthy range. It has increased from 10.50 (Mar 24) to 11.18, marking an increase of 0.68.
• For PBDIT Margin (%), as of Mar 25, the value is 52.06. This value is within the healthy range. It has increased from 50.82 (Mar 24) to 52.06, marking an increase of 1.24.
• For PBIT Margin (%), as of Mar 25, the value is 37.97. This value exceeds the healthy maximum of 20. It has increased from 36.59 (Mar 24) to 37.97, marking an increase of 1.38.
• For PBT Margin (%), as of Mar 25, the value is 18.65. This value is within the healthy range. It has decreased from 18.72 (Mar 24) to 18.65, marking a decrease of 0.07.
• For Net Profit Margin (%), as of Mar 25, the value is 16.68. This value exceeds the healthy maximum of 10. It has increased from 14.87 (Mar 24) to 16.68, marking an increase of 1.81.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 16.60. This value is within the healthy range. It has increased from 14.99 (Mar 24) to 16.60, marking an increase of 1.61.
• For Return on Networth / Equity (%), as of Mar 25, the value is 7.13. This value is below the healthy minimum of 15. It has decreased from 8.26 (Mar 24) to 7.13, marking a decrease of 1.13.
• For Return on Capital Employeed (%), as of Mar 25, the value is 5.70. This value is below the healthy minimum of 10. It has decreased from 8.24 (Mar 24) to 5.70, marking a decrease of 2.54.
• For Return On Assets (%), as of Mar 25, the value is 2.16. This value is below the healthy minimum of 5. It has decreased from 2.95 (Mar 24) to 2.16, marking a decrease of 0.79.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 1.64. This value exceeds the healthy maximum of 1. It has increased from 1.33 (Mar 24) to 1.64, marking an increase of 0.31.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.81. This value exceeds the healthy maximum of 1. It has increased from 1.50 (Mar 24) to 1.81, marking an increase of 0.31.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.15. It has decreased from 0.21 (Mar 24) to 0.15, marking a decrease of 0.06.
• For Current Ratio (X), as of Mar 25, the value is 1.03. This value is below the healthy minimum of 1.5. It has decreased from 1.19 (Mar 24) to 1.03, marking a decrease of 0.16.
• For Quick Ratio (X), as of Mar 25, the value is 0.95. This value is below the healthy minimum of 1. It has decreased from 1.08 (Mar 24) to 0.95, marking a decrease of 0.13.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 17.91. This value is below the healthy minimum of 20. It has decreased from 19.09 (Mar 24) to 17.91, marking a decrease of 1.18.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 9.69. This value is below the healthy minimum of 20. It has decreased from 9.80 (Mar 24) to 9.69, marking a decrease of 0.11.
• For Earning Retention Ratio (%), as of Mar 25, the value is 82.09. This value exceeds the healthy maximum of 70. It has increased from 80.91 (Mar 24) to 82.09, marking an increase of 1.18.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 90.31. This value exceeds the healthy maximum of 70. It has increased from 90.20 (Mar 24) to 90.31, marking an increase of 0.11.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.69. This value is below the healthy minimum of 3. It has decreased from 2.84 (Mar 24) to 2.69, marking a decrease of 0.15.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.86. This value is below the healthy minimum of 3. It has increased from 1.83 (Mar 24) to 1.86, marking an increase of 0.03.
• For Enterprise Value (Cr.), as of Mar 25, the value is 140,491.85. It has increased from 114,106.64 (Mar 24) to 140,491.85, marking an increase of 26,385.21.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 11.96. This value exceeds the healthy maximum of 3. It has increased from 9.93 (Mar 24) to 11.96, marking an increase of 2.03.
• For EV / EBITDA (X), as of Mar 25, the value is 22.98. This value exceeds the healthy maximum of 15. It has increased from 19.55 (Mar 24) to 22.98, marking an increase of 3.43.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 7.99. This value exceeds the healthy maximum of 3. It has increased from 7.56 (Mar 24) to 7.99, marking an increase of 0.43.
• For Retention Ratios (%), as of Mar 25, the value is 82.08. This value exceeds the healthy maximum of 70. It has increased from 80.90 (Mar 24) to 82.08, marking an increase of 1.18.
• For Price / BV (X), as of Mar 25, the value is 3.43. This value exceeds the healthy maximum of 3. It has decreased from 4.17 (Mar 24) to 3.43, marking a decrease of 0.74.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 7.99. This value exceeds the healthy maximum of 3. It has increased from 7.56 (Mar 24) to 7.99, marking an increase of 0.43.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness